Oxigene Inc fka OXGN

[Techsource]

Combine AVASTIN with ZYBRESTAT and you got the cancer cure.

After the failure of AVASTIN Roche will go after ZYBRESTAT to combine killing tumors with preventing growth of new tumors (veins to them). They drug could not work by itself (preventing tumor growth), they need the power of ZYBRESTAT to kill the tumor first.

ZYBRESTAT should be used first and then AVASTIN

Hopefully Roche and OXYGENE will find each other soon-actually they did and Phase I study has started. Roche is a BIG Partner.


% Held by Insiders6: 38.69%
% Held by Institutions6: 8.50%

1570% down

worth $1.50-$2.50 as it is